WELLS FARGO & COMPANY/MN - LIXTE BIOTECHNOLOGY HLDGS IN ownership

LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 12 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q1 2023$44
+69.2%
53
+1.9%
0.00%
Q4 2022$2652
+2.0%
0.00%
Q3 2022$051
+4.1%
0.00%
Q2 2022$049
+81.5%
0.00%
Q1 2022$0270.0%0.00%
Q4 2021$0270.0%0.00%
Q3 2021$027
+68.8%
0.00%
Q2 2021$0160.0%0.00%
Q1 2021$0160.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q1 2023
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 166,667$124,0000.09%
SABBY MANAGEMENT, LLC 99,644$74,0000.05%
Almanack Investment Partners, LLC. 248,084$185,0000.02%
Warberg Asset Management LLC 14,500$11,0000.00%
TWO SIGMA INVESTMENTS, LP 16,948$13,0000.00%
WELLS FARGO & COMPANY/MN 49$00.00%
GEODE CAPITAL MANAGEMENT, LLC 25,794$19,0000.00%
STATE STREET CORP 35,956$28,0000.00%
MORGAN STANLEY 71,054$53,0000.00%
Citadel Advisors 30,063$23,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders